Early onset drusen and RPE dysfunction in a patient with NLRP3-AID

Area of Science:

• Ophthalmology
• Immunology
• Genetics

Background:

• Retinal pigment epithelium (RPE) dysfunction, characterized by drusen and mottling, is common in aging but its mechanisms are unclear.
• Animal studies suggest NLRP3 inflammasome activation in RPE causes cell death and may contribute to age-related macular degeneration (AMD).
• Clinical evidence linking NLRP3 inflammasome to RPE dysfunction and AMD is lacking.

Observation:

• A case report details a 38-year-old Chinese Han woman with NLRP3-associated autoinflammatory disease (NLRP3-AID).
• This patient presented with widespread posterior pole drusen in both eyes.
• NLRP3-AID is a rare genetic disorder resulting from NLRP3 gene mutations, leading to constitutive NLRP3 inflammasome activation.

Findings:

• The patient's presentation of early-onset drusen in the context of NLRP3-AID offers a unique clinical observation.
• This case provides the first direct clinical evidence supporting the hypothesis that NLRP3 inflammasome activation contributes to RPE dysfunction.
• The findings suggest a potential role for the NLRP3 inflammasome in the pathogenesis of AMD.

Implications:

• This study highlights the NLRP3 inflammasome as a potential therapeutic target for AMD.
• Understanding the link between NLRP3-AID and RPE dysfunction could lead to novel diagnostic and treatment strategies for AMD.
• The findings underscore the importance of considering systemic autoinflammatory conditions in the differential diagnosis of early-onset retinal findings.